Tech Company Financing Transactions
Kinex Pharmaceuticals Funding Round
Kinex Pharmaceuticals, based in Buffalo, secured $74.4 million from private investors.
Transaction Overview
Company Name
Announced On
6/16/2015
Transaction Type
Venture Equity
Amount
$74,399,996
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
701 Ellicott St.
Buffalo, NY 14203
USA
Buffalo, NY 14203
USA
Phone
Website
Email Address
Overview
Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Johnson Lau
Chief Medical Officer
Rudolf Kwan
Chief Operating Officer
Flint Besecker
Chief Scientific Officer
David Hangauer
Browse more venture capital transactions:
Prev: 6/16/2015: Connectifier venture capital transaction
Next: 6/16/2015: GreenLight Biosciences venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs